Ardelyx reported $246.97M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 2.94M Mar/2026
Amgen USD 541M 1000K Jun/2026
Ardelyx USD 246.97M 2.62M Mar/2026
aTyr Pharma USD 62.99M 46.35M Mar/2026
Corcept Therapeutics USD 107.33M 1.36M Mar/2026
Curis USD 2M 10.93M Mar/2026
Sanofi EUR 1.2B 16.88M Mar/2026
TG Therapeutics USD 155.31M 95K Dec/2025
United Therapeutics USD 42.68M 521K Jun/2026